Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance

To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized in double blind fashion to placebo or pioglitazone for diabetes prevention in the ACT NOW stu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Age (Dordr)
Asıl Yazarlar: Espinoza, Sara E., Wang, Chen-pin, Tripathy, Devjit, Clement, Stephen C., Schwenke, Dawn C., Banerji, Mary Ann, Bray, George A., Buchanan, Thomas A., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Stentz, Frankie B., Reaven, Peter D., DeFronzo, Ralph A., Musi, Nicolas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266219/
https://ncbi.nlm.nih.gov/pubmed/27585671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-016-9946-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller